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Arieska Ann Soenarta
Hypertension (HT) the  most  important  risk factor 
of  cardiovascular disease (CVD), is a  heterogeneous 
disease; the underlying  cause  is  unknown.  Genetic 
back-ground and environmental influences are both 
involved.  The  most  important  environmental  fac-
tors  are  physical  inactivity  and  dietary  factors, 
particularly  salt  and  potassium  intake.1 
There  is  a  relationship  between  Blood Pressure 
(BP)  and  natriuresis which  maintains  sodium  bal-
ance  and  extra cellular  fluid  volume. An impaired 
ability  of  the  kidney  to  excrete  sodium, requires  an 
increase  in  BP  to  increase natriuresis  and  correct 
sodium balance  resulting  in  HT. Much  evidence 
suggests, that  in  those  who  develops  high  BP, there 
is   an  underlying  defect in  the  ability  of  the  kidney 
to  excrete  salt  and   that  the  greater  compensatory 
response  required  to  restore  sodium balance  is  the 
cause  for the  increase  in BP.2,3 Epidemiological, mi-
gration, intervention, treatment, genetic and animal 
studies have  shown  that  dietary  salt (sodium chlo-
ride) plays  an  important  role  in  BP regulation.4 The 
INTERSALT  study, the EPIC-Norfolk study  and 
many other  studies  have shown that BP was  higher 
among  subjects  with  a  high  sodium  intake.1,5
The meta-analysis of  randomized  trials  by  J E 
He  and G A MacGregor  showed  a dose  response 
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between  the  change  of  urine  sodium  and   BP. A 
reduction  of  6g  of  salt  intake  resulted  in  a  fall 
in  BP  of  7.11/3.88mmHg (p< 0.001  for  systolic 
and diastolic) in  HT’s  and  3.57/1.66 mmHg  in 
normotensive’s  (systolic :p<0.001;diastolic: p<0.05). 
This  will  predict  the  reduction  in  stroke deaths 
by 14% and  coronary  deaths  by  9%  in  HT’s and 
reduction in stroke  and  coronary  deaths  by  6 and 
4%  in  normotensive’s  respectively.6 
There  is  an  increase  evidence  that  high  salt 
intake  has  direct  harmful  effects on  the  CV  system 
e.g : an increase  Left Ventricular Mass (LVM), stiff-
ness  of  the conduit  arteries  thickens  and  narrows 
resistance  arteries  independent to  the  effect  of  salt 
and  BP. An increase in sodium concentration directly 
exerts growth stimulating intracellular signals. 
Many studies  have  shown  a  positive  correla-
tion  between  urinary  sodium  excretion  and  LVM 
in  normotensive’s  well  as  in  HT’s. A  reduction 
in  salt  intake  is  associated  with  a  reduction  of 
LVM2,7-9 at  VASCULAR   level. High  salt  intake 
induce  significant structural  alterations   of arteries, 
cerebral - as  well  as  renal  arteries, independent  of 
BP  levels. Salt loading independently has been shown 
to decrease NO reduction. Salt reduction improves 
endothelial dependent  vasodilatation  in  normoten-
sive’s  independent of  BP.10-12 
KIDNEY  and  salt. High sodium  intake  was 
shown  to  increase  glomerular filtration  and  an  in-
crease  in  intra glomerular  pressure. The  impact  of 
salt  intake on  renal  function  is  its  effect  on  albu-
min  excretion.  Lowering  salt  intake  in proteinuric 
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patients  is  associated  with  reduction  in  proteinurie. 
Indeed   several epidemiologic  studies  have  shown  a 
direct  association  between  salt  intake and  urinary 
albumin  excretion, independent   of  BP.13 
Salt  intake  and  STROKE.  The results  of  a  meta 
analysis  from  13  studies  with  177.025    participants 
showed  that  higher  salt  intake  was  associated  with 
a  greater  risk  of  stroke  and  CVD, a 23 %  greater 
risk  of  stroke  for  an  average difference  in  sodium 
intake  of  5g/d (one teaspoon).14 Cook et. al  reported 
the  long term  effects  of  salt  reduction  in  CVD, a 
25 to 35 % lower  incidence  of  CV events  was  noted 
in  the  reduced  salt  group.15 It has  been  estimated 
that  a  3g/d  reduction  of  dietary  salt  intake  would 
reduce  stroke  by  13 %  and  Ischemic  heart  disease 
by  10 %(NHANES I).The  average  salt  intake  in 
most  countries  around  the  world  is  about  9 to 
12g/d. The  Asian  countries  more  than  12g/d.3  The 
World  Health  Organization  recommendations  for 
adults  are  to  reduce  salt  intake  to < 5g/d, the UK 
and  the  USA  recommendations  are < 6g/d. These 
recommendations  will  have  a major  impact  on 
BP  and  CVD  but  are  not  ideal. A  reduction  to 
3g/d  will  have a  much  greater  effect  and  should 
become  the  long-term  target  for  population salt 
intake  worldwide.16 Evidence  shows  that  current 
salt  intake  contribute  to  the  high  prevalence  of 
HT  and  its  consequences. 
Public Health  efforts  to  reduce  salt  intake  are 
justified   especially   in  commercial  foods.17
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